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Long-Term Follow-Up of Incomplete Stent Apposition in
Patients Who Received Sirolimus-Eluting Stent for De Novo
Coronary Lesions
An Intravascular Ultrasound Analysis
Muzaffer Degertekin, MD; Patrick W. Serruys, MD, PhD; Kengo Tanabe, MD; Chi Hang Lee, MBBS;
J. Edouardo Sousa, MD, PhD; Antonio Colombo, MD; Marie-Claude Morice, MD;
Jurgen M.R. Ligthart, BSc; Pim J. de Feyter, MD, PhD
Background—Incomplete stent apposition (ISA) has been previously documented after sirolimus-eluting stent (SES)
implantation. The aim of this study was to investigate the long-term intravascular ultrasound (IVUS) findings of ISA
in patients who received SES.
Methods and Results—A total of 13 patients who received SES and showed ISA at follow-up IVUS (follow-up I) were
investigated. IVUS was performed on all of these patients 12 months later (follow-up II). Quantitative ISA area
measurement was also performed at follow-up I and II. No vascular remodeling was observed in the vessel segment with
ISA; external elastic membrane area was 19.46.6 versus 19.56.4 mm2 at follow-up I and II, respectively. There was
also no significant change in external elastic membrane area between vessel segment with ISA and without ISA (1.5%
versus 3.0%, respectively; P0.27) at late follow-up. The ISA area, either including (2.51.7 versus 3.86.3 mm2;
PNS) or excluding (2.51.8 versus 2.41.7 mm2; PNS) a single patient with aneurysm formation, was not
significantly different between follow-up I and II. One patient manifested a coronary aneurysm in the stented segment
at late follow-up that was probably present at the initial follow-up but masked by thrombus. It was successfully treated
with a covered stent. All patients were asymptomatic, and no patient experienced late thrombotic occlusion.
Conclusions—Vessel dimensions and area of ISA did not change over time, except for 1 coronary aneurysm that became
apparent. ISA after implantation of a SES was not associated with adverse events at late follow-up. (Circulation. 2003;
108:2747-2750.)
Key Words: stents  vessels  coronary disease
The RAVEL (RAndomized study with the sirolimus-eluting Bx-VELOCITY stent) trial recently demon-
strated that sirolimus-eluting stent (SES) effectively inhibits
neointimal hyperplasia (NIH) without showing edge narrow-
ing, thrombotic occlusion, or persistence of dissection.1,2
However, incomplete stent apposition (ISA) was observed
during follow-up intravascular ultrasound (IVUS) in patients
who received SES.2
ISA has been shown to occur after brachytherapy as well as
in patients who receive bare metal stents (BS).3,4 Clinical
outcomes of patients who developed ISA remain controver-
sial. Furthermore, there are no data on serial IVUS evaluation
of ISA in the long-term follow-up. Because drug-eluting
stents (DES) may potentially become a routine therapy in
interventional cardiology, information on the long-term ef-
fects of ISA with DES are eagerly awaited. The aim of our
study was to investigate the long-term quantitative IVUS
findings of ISA in patients who received SES.
Methods
Patient Population
In the RAVEL1 and First-in-Man5 trials, 168 patients received SES
for single de novo coronary lesions and a subset of 91 patients
underwent IVUS investigation at follow-up. In this report, a total of
13 patients who showed ISA at 6 or 12 months follow-up (follow-up
I) were included, and quantitative IVUS was performed on all of
these patients 12 months later (follow-up II).
Evaluation of ISA, Quantitative IVUS, and
Coronary Angiography Analysis
IVUS was performed with automated pullback at 0.5 mm/s. All
IVUS procedures were recorded on VHS videotapes. ISA was
defined as 1 or more stent struts clearly separated from the vessel
wall with evidence of blood speckles behind the strut without
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overlapping side branches.2 As previously reported, the maximum
number of struts separated from the vessel wall, maximal depth, and
angle of the ISA were documented.2 The length of ISA site was
measured from single or multiple longitudinal views. When the
patient had 1 ISA sites separated from each other by completely
well-apposed stented segment, the total length of ISA was defined as
the sum of the lengths of each ISA segment.
In the segment with ISA, the lumen contours were delineated
within and outside the stent strut boundaries (stent area [SA]) (Figure
1). The quantitative coronary ultrasound analysis software (Curad
BV, Wijk Bij) was modified to calculate the fraction of the lumen
area that lies outside of the stent, eg, ISA area.6 ISA is thus
conceptually considered part of an effective lumen. Therefore, 2
types of lumen area are reported: the intrastent lumen area (SA minus
intrastent neointimal hyperplasia area) and the effective lumen area
(sum of ISA area and intrastent lumen area). In addition, in the
segment with ISA, external elastic membrane area (EEMA) and
plaque behind stent area (EEMA minus SA minus ISA area) were
measured (Figure 1).
Coronary artery aneurysm (CAA) was defined as a maximum
lumen area 50% larger than the proximal reference lumen area,
which is a cross section of normal appearance within 5 mm proximal
to the stent.7 Quantitative coronary angiography was performed by
independent core laboratory, as previously described.1,5
Statistical Analysis
Quantitative data are presented as mean1 SD and compared using
paired Student’s t test. Treatment group differences were tested by
ANOVA of Wilcoxon rank-sums scores. Consecutive quantitative
coronary angiography measurements were analyzed by general linear
modeling with repeated measures, considering various times as
factors. A value of P0.05 was considered statistically significant.
Results
Of 13 patients, 8 were men (age, 58.411.6 years). Cardiac
risk factor included hypercholesterolemia in 4 and hyperten-
sion in 5. No patient had diabetes. All patients were asymp-
tomatic, and none experienced late thrombotic occlusion or
in-stent restenosis 1 year after the diagnosis of ISA. Coronary
angiography demonstrated persistent minimal late loss at late
follow-up (Table 1).
Table 2 shows serial IVUS measurements of stented
segments with ISA. There was no significant difference in
either EEMA or plaque behind stent area between follow-up
I and II. NIH remained minimal at late follow-up. There was
also no significant change in EEMA between vessel segment
with ISA and without ISA (1.5% versus 3.0%, respec-
tively; P0.27) at late follow-up.
Figure 2A illustrates individual data on ISA volume at the
2 time points. At follow-up I, 22 ISA sites were found; 1 of
13 patients (4.5%) had 3 and 7 of 13 patients (31.8%) had 2
separate ISA sites. At follow-up II, the patient who had 3 ISA
sites had developed an aneurysm covering the previous 2 ISA
sites; apart from this patient, no new ISA sites were observed.
Indeed, 4 ISA sites had resolved at follow-up II.
Figure 1. Longitudinal IVUS image of a patient who has a segment with ISA. Cross-sectional views correspond to the section (*) of the
longitudinal view showing the red, yellow, blue, and green lines that indicate the of external elastic membrane contour, the stent con-
tour, effective lumen area contour, and intrastent lumen area contour, respectively. PBS indicates plaque behind the stent.
TABLE 1. Serial Quantitative Coronary Angiography
Parameters (n13) Post Follow-Up I Follow-Up II
Reference diameter, mm 2.980.48 3.000.46 2.930.49
Minimum lumen diameter, mm 2.720.46 2.640.53 2.460.61
Diameter stenosis, % 8.96.7 11.910.5 16.014.6
In-stent late lumen loss, mm    0.070.29 0.260.46*
Data are presented as No. relative percentages or meanSD.
*P0.04, follow-up I vs follow-up II.
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The ISA area, either including (2.51.7 versus 3.86.3 mm2;
PNS) or excluding (2.51.versus 2.41.7 mm2; PNS) a
single patient with aneurysm formation, was not significantly
different between follow-up I and II. In this patient with
aneurysm, the border of external elastic membrane could not be
delineated on 6-month IVUS. However, serial IVUS examina-
tions suggesting dissolution of thrombotic material in a preex-
isting aneurysm (Figure 2B). This aneurysmal sac with a depth
of 5.9 mm was successfully treated by implanting a covered
stent.
Discussion
The main findings of our analysis are as follows: (1) ISA after
implantation of a SES is not associated with adverse clinical
events 1 year after the diagnosis; (2) the vessel segment
surrounding the incompletely apposed stent does not show
positive vascular remodeling over time; (3) ISA area does not
significantly change at late follow-up; and (4) inhibition of
in-stent NIH persists during long-term follow-up.
ISA after implantation of SES has been a major concern
since it was first described.2 The present study demonstrated
that clinical course of ISA observed after SES implantation
was benign; none of the patients with ISA experienced stent
thrombosis or myocardial infarction. The absence of events,
even in the presence of ISA, is also consistent with the
observation that endothelialization after implantation of SES
and BS is similar and that SES is less thrombogenic than BS.8
The underlying mechanism for ISA remains largely un-
known. Several hypotheses have been postulated, including
plaque regression, regional positive vascular remodeling, late
dissolution of thrombotic material trapped behind the stent,
cell necrosis, apoptosis, and allergic reaction to
sirolimus.4,9–11
Any dilatation of the vessel lumen raises concern about
progressive dilatation over time, aneurysm formation, and
ultimately the potential of rupture, as is seen with aortic
aneurysms. We observed 1 case of CAA in the SES-stented
segment 1 year after the diagnosis of ISA. Although there was
no IVUS image from the index procedure, the angiograms
after the index procedure and at 6-month follow-up were
similar (Figure 2). Therefore, we suspected that there was a
Figure 2. A, Volume changes of incomplete stent apposition
(per patient) between 2 time intervals. *Patient who showed cor-
onary aneurysm. B, Serial coronary angiography shows small
pouching (arrow) at 6-month follow-up (6M). At 18-month
follow-up (18M), coronary aneurysm exists at the same locality
of pouching. In the IVUS (bottom), at 6M, homogeneous, low-
echogenic solid mass suggests thrombus behind the stent
struts. At 18M IVUS, this mass is dissolved with blood flow at
the same (*) area, consistent with aneurysm formation, suggest-
ing dissolution of thrombotic material.
TABLE 2. Serial Quantitative Intravascular Ultrasound Analysis of Vessel
Segment Showing Incomplete Stent Apposition (n12)*
Follow-Up I Follow-Up II P
Length of the ISA segment, mm 5.13.5 4.82.6 0.36
External elastic membrane area, mm2 19.46.6 19.56.4 0.86
Maximal depth of the ISA segment, mm 0.80.3 0.90.4 0.63
Maximal circumferential extent of the ISA, arc 13866 14466 0.83
Maximal No. of struts separated from vessel wall
on 1 single cross section
3.30.8 3.251.4 0.79
Mean ISA area, mm2 2.51.8 2.41.7 0.60
Plaque behind stent area, mm2 9.024.2 9.23.9 0.95
Stent area (strut boundaries), mm2 7.952.40 8.152.31 0.57
Intrastent (NIHA), mm2 0.020.01 0.050.04 0.047
Intrastent lumen area (stent area minus NIHA), mm2 7.922.39 8.092.33 0.42
Effective lumen area, mm2
(Lumen area within the stent plus ISA area)
10.43.6 10.33.4 0.88
Values are meanSD. NIHA indicates neointimal hyperplasia area.
*Patient who showed coronary aneurysm is not included because of lack of external elastic
membrane measurement.
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preexisting CAA filled with thrombus at the time of the index
procedure and that this thrombotic material had been resolved
at 18 months. Based on the fact that elution of sirolimus from
the stent struts continues for only 6 weeks, with a half-life of
sirolimus in the tissue of 60 hours (R. Falotico, personal
communication, 2002), sirolimus itself is unlikely to induce
structural vessel wall changes in the longer term. Neverthe-
less, it remains difficult to rule out formation of CAA after
SES implantation. It is worth noting that CAA is well known
after BS implantation, balloon angioplasty, and coronary
atherectomy.12,13
Excluding the aneurysm case, the vessel segment related to
the incompletely apposed stent did not significantly alter in
size (1.5% change in EEMA) at late follow-up, and mean
ISA area also did not significantly change. Moreover, negli-
gible amount of NIH at late follow-up showed that the
efficacy of SES in inhibiting neointimal tissue migration and
proliferation was not affected by the presence of ISA.
Therefore, because ISA per se was not associated with any
additional adverse events, we suggest that there is no need for
late mechanical correction of these cases of ISA.
Conclusions
ISA after implantation of a SES was not associated with
adverse events 1 year after the diagnosis. ISA area and vessel
dimensions in the segments including ISA did not change
over time.
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